Financial Summary (All financials)
| In millions, except per share items | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 |
| Revenues | 164.0 | 204.6 | 232.8 | 156.1 | 75.8 |
| Revenue growth | -19.8% | -12.1% | 49.1% | 106.1% | |
| Cost of goods sold | 133.1 | 155.1 | 146.1 | 102.7 | 50.0 |
| Gross profit | 30.9 | 49.5 | 86.7 | 53.4 | 25.7 |
| Gross margin | 18.9% | 24.2% | 37.2% | 34.2% | 33.9% |
| Selling, general and administrative | 48.2 | 46.3 | 42.3 | 23.1 | 14.2 |
| Research and development | 27.6 | 42.6 | 34.3 | 21.4 | 11.4 |
| EBIT | -44.9 | -39.4 | 10.1 | 8.9 | 0.1 |
| EBIT margin | -27.4% | -19.3% | 4.3% | 5.7% | 0.2% |
| Pre-tax income | -42.8 | -33.7 | 16.5 | 7.7 | 0.3 |
| Income taxes | -0.3 | 6.9 | 5.8 | -7.2 | 0.1 |
| Tax rate | 0.7% | | 35.2% | | 24.6% |
| Net income | -42.5 | -40.6 | 10.7 | -33.5 | -67.8 |
| Net margin | -25.9% | -19.8% | 4.6% | -21.4% | -89.5% |
| |
| Diluted EPS | $0.00 | $0.00 | $0.00 | ($3.78) | ($8.48) |
| Shares outstanding (diluted) | 50.8 | 50.2 | 35.7 | 8.9 | 8.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|